Open AccessCYP2C19 PHARMACOGENETIC TESTING FOR PERSONALIZATION OF ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME IN ROUTINE CLINICAL PRACTICE
Author(s) -
Irina Akhmetova,
Е Б Клейменова,
Д. А. Сычев,
О В Паршина,
L. P. Yashina
Publication year - 2017
Publication title -
racionalʹnaâ farmakoterapiâ v kardiologii
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.161
H-Index - 9
eISSN - 2225-3653
pISSN - 1819-6446
DOI - 10.20996/1819-6446-2017-13-6-771-775
Subject(s) - medicine , clopidogrel , cyp2c19 , ticagrelor , acute coronary syndrome , pharmacogenetics , genotyping , prasugrel , cardiology , genotype , aspirin , myocardial infarction , biochemistry , chemistry , cytochrome p450 , metabolism , gene